Expression of a functional anaphylatoxin C3a receptor by astrocytes

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2487-2496

  Ischenko, Alexander ^a   Sayah, Sakina ^b,c   Patte, Christine ^b,c   Andreev, Serguey ^a   Gasque, Philippe ^d   Schouft, Marie Thérèse ^b,c   Vaudry, Hubert ^b,c   Fontaine, Marc ^b,c  

^a State Res Inst Highly Pure B   (Russian Federation)

^b Europ Inst Peptide Res IFRMP 23   (France)

^c INSERM   (France)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anaphylatoxin C3a; Astrocyte; Complement; Inflammation; Receptor

Indexed keywords

ANAPHYLATOXIN; CALCIUM ION; CARBOXYPEPTIDASE B; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENTARY DNA; MESSENGER RNA; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BINDING SITE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DNA SEQUENCE; ENCEPHALITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCATCHARD PLOT;

EID: 0031741881     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062487.x     Document Type: Article

References (37)

1. Ames R. S., Li Y., Sarau H. M., Nuthulaganti P., Foley J. J., Ellis C., Zeng Z., Su K., Jurewicz A. J., Hertzber R. P., Bergsma D. J., and Kumar C. (1996) Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271, 20231-20234.
2. Barnum S. R., Ishii Y., Agrawal A., and Volanakis J. E. (1992a) Production and interferon-gamma mediated regulation of complement component C2 and factor-B and factor-D by the astroglioma cell line U105-MG. Biochem. J. 287, 595-601.
3. Barnum S. R., Jones J., and Benveniste E. N. (1992b) Interferon-gamma regulation of C3-gene expression in human astroglioma cells. J. Neuroimmunol. 38, 275-282.
4. Bischoff S. C., Deweck A. L., and Dahinden C. A. (1990) Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc. Natl. Acad. Sci. USA 87, 6813-6817.
5. Boulay F., Mery L., Tardif M., Brouchon L., and Vignais P. (1990) Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL60 cells. Biochemistry 30, 2993-2999.
6. Crass T., Raffetseder U., Martin U., Groue M., Klos A., Kohl J., and Bautsch W. (1996) Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur. J. Immunol. 26, 1944-1950.
7. Ember J. A., Johansen N. L., and Hugli T. E. (1991) Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry 30, 3603-3612.
8. Fraker P. J. and Speck J. C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3,6-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
9. Fukuoka Y. and Hugli T. E. (1988) Demonstration of a specific C3a receptor on guinea-pig platelets. J. Immunol. 148, 3496-3501.
10. Gasque P., Julen N., Ischenko A. M., Picot C., Mauger C., Chauzy C., Ripoche J., and Fontaine M. (1992) Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149, 1381-1387.
11. Gasque P., Ischenko A. M., Legoedec J., Mauger C., Schouft M. T., and Fontaine M. (1993) Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem. 268, 25068-25074.
12. Gasque P., Fontaine M., and Morgan B. P. (1995a) Complement expression in human brain: biosynthesis of the terminal pathway components and regulators in human glial cell lines. J. Immunol. 154, 4726-4733.
13. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Gotze O., and Morgan B. P. (1995b) Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155, 4882-4889.
14. Gasque P., Thomas A., Fontaine M., and Morgan B. P. (1996a) Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J. Neuroimmunol. 66, 29-40.
15. Gasque P., Legoedec J., Thomas A., Schouft M. T., Chan P., and Fontaine M. (1996b) Local synthesis of the complement system: new functions for the complement system. Med. Sci. 12, 941-947.
16. Gasque P., Singharo S. K., Neal J. W., Gotze O., and Morgan B. P. (1997) Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150, 31-41.
17. Gerard N. P. and Gerard C. (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
18. Gerardy-Schahn R., Ambrosius D., Saunders D., Casaretto M., Mittler C., Karwarth G., Gorgen S., and Bitter-Suermann D. (1989) Characterization of C3a receptor, proteins on guinea-pig platelets and human polymorphonuclear leukocytes. Eur. J. Immunol. 19, 1095-1102.
19. Gordon D. L., Avery V. M., Adrian D. L., and Sadlon T. A. (1992) Detection of complement mRNA in human astrocytes by polymerase chain reaction. J. Neurosci. Methods 45, 191-197.
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
21. Haga S., Ikeda K., Sato M., and Ishii T. (1993) Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601, 88-94.
22. Hugli T. E. (1975) Human anaphylatoxin (C3a) from the third component of complement: primary structure. J. Biol. Chem. 250, 8293-8301.
23. Hugli T. E. (1984) The structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 7, 193-219.
24. Johnson S. A., Lampertetchells M., Pasinetti G. M., Rozovsky I., and Finch C. E. (1992) Complement messenger RNA in the mammalian brain. Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13, 641-648.
25. 125I-C3a binding. Biochemistry 31, 11274-11282.
26. Laemmli U. K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 221, 680-685.
27. Lévi-Strauss M. and Mallat M. (1987) Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol. 139, 2361-2366.
28. i signaling in mouse microglia. J. Neurosci. 17, 615-624.
29. Murakami Y., Imamichi T., and Nagasawa S. (1993) Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages. Immunology 70, 633-638.
30. 2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur. J. Biochem. 217, 289-294.
31. Roglic A., Prossnitz E. R., Cavanagh S. L., Pan Z., Zoo A., and Ye R. D. (1996) cDNA cloning of a novel G-protein-coupled receptor with a large extracellular loop structure. Biochim. Biophys. Acta 1035, 39-43.
32. Rus H. G., Kim L. M., Niculescu F. I., and Shin M. E. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J. Immunol. 148, 928-933.
33. Sayah S., Patte C., Gasque P., Chan P., Ischenko A., Vaudry H., and Fontaine M. (1997) Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of its expression by rat astrocytes. Mol. Brain Res. 48, 215-222.
34. Schupf N., Williams C. A., Hugli T. E., and Cox J. (1983) Psychopharmacological activity of anaphylatoxin C3a in the rat hypothalamus. J. Neuroimmunol. 5, 305-316.
35. Walker D. and McGeer P. (1993) Complement gene expression in neuroblastoma and astrocytoma cell lines of human origin. Neurosci. Lett. 157, 99-102.
36. Williams C. A., Schupf N., and Hugli T. E. (1985) Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9, 29-40.
37. Williams C. A., Schupf N., Reilly C. L., and Wagner J. (1988) Complement peptides and neuronal dysfunction in the central nervous system: specificity of receptor sites for anaphylatoxin C3a activity in the rat hypothalamus. Drug Dev. Res. 15, 175-187.